| BRXAX | MDIHX | BRXAX / MDIHX | |
| Total Expense Ratio | 0.77 | 1.08 | 71% |
| Annual Report Gross Expense Ratio | 0.77 | 1.10 | 70% |
| Fund Existence | 10 years | 21 years | - |
| Gain YTD | 34.301 | 21.844 | 157% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 44.2B | 5% |
| Annual Yield % from dividends | 2.37 | 1.84 | 129% |
| Returns for 1 year | 33.59 | 21.09 | 159% |
| Returns for 3 years | 68.03 | 40.52 | 168% |
| Returns for 5 years | 56.85 | 24.90 | 228% |
| Returns for 10 years | 103.87 | 102.24 | 102% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVOAX | 13.32 | N/A | N/A |
| SEI US Managed Volatility F (SIMT) | |||
| SXPCX | 54.46 | -0.01 | -0.02% |
| DWS S&P 500 Index C | |||
| JFNCX | 67.74 | -0.17 | -0.25% |
| Janus Henderson Global Life Sciences C | |||
| VSFCX | 22.40 | -0.06 | -0.27% |
| Federated Hermes MDT Small Cap Value C | |||
| PHPSX | 29.67 | -0.13 | -0.44% |
| ProFunds Pharmaceuticals UltraSector Svc | |||